Completed NA INTERVENTIONAL 2-arm NCT04382521

A Text Message Intervention to Promote Health Behaviors in Cardiac Risk Conditions

Sponsor: Massachusetts General Hospital

Conditions Hyperlipemia Hypertension Type2 Diabetes

Updated 7 times since 2020 Last updated: Jul 27, 2023 Started: Sep 22, 2020 Primary completion: Apr 15, 2023 Completion: Apr 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Hyperlipemia and Hypertension, this trial is completed. The trial is conducted by Massachusetts General Hospital and has accumulated 7 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Aug 2023 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Mar 2023 — Aug 2023 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Mar 2021 — Mar 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting NA
Jun 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Massachusetts General Hospital

Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States